Search

The nuclear industry has welcomed European Commission plans for a concerted effort on small modular reactors. A new international consortium plans to demonstrate the technology in Belgium

There is growing pressure on EU policymakers to play a role in promoting the development of psychedelics as medicines. The pharmaceutical regulations reform is an opportunity to incentivise research say MEPs

A bi-monthly newsletter with news and analysis on R&I policy in central and eastern Europe

Two wars hung over this year’s get-together of scientists and politicians in Berlin. But there was still plenty of excitement, and trepidation, about new breakthroughs in AI, solar energy, and transatlantic science

The EDCTP partnership that sponsors clinical trials in Africa is a flagship of the EU’s health research effort. But as it reaches its 20 anniversary the pending pharmaceutical legislation and budget worries dog its future, warns Maria da Graça Carvalho MEP

The dean of the geodesy faculty and a fellow professor are accused of stealing from projects funded through the European Regional Development Fund and the EU Solidarity Fund

French MEP Gwendoline Delbos-Corfield has a ‘creative’ answer to the current stalemate, saying rule of law concerns could be circumvented by handing the management of EU research funding to an independent body

Drawn by the generous terms of NATO’s Diana accelerator and mobilised by the war in Ukraine, start-ups in central and eastern Europe are opening up to adapting their technologies for use in defence

Research commissioned by lobby group EFPIA shows Germany, Belgium and France will be among those hit hardest if the Commission’s proposals go ahead. In total, R&D would be cut by €2B per annum

Iliana Ivanova says it’s her ‘personal priority’ to secure more association deals with non-EU countries in the coming months

European Commission research suggests awarding grants to early career researchers and involving industry is good for innovation

The head of a biotech start-up tells how the war has upended his company and the wider Israeli ecosystem. The normal rules of capitalism have been relaxed, with rival start-ups and venture capitalists now helping each other out